Corrigendum
First published: 27 January 2021
In the original published version of the paper of Giallauria et al.1 the data in Table 1, under treatment (n = 36) column, 63.8 value was incorrect and has been changed to 94.4 in the online version. This change is marked in bold in the updated table below.
Table 1. Characteristics of the trials included
| REDUCE FMR trial | TITAN trial | TITAN II trial | |||
|---|---|---|---|---|---|
| Treatment (n = 73) | Control (n = 47) | Treatment (n = 36) | Control (n = 17) | Treatment (n = 36) | |
| Gender (male) (%) | 72.4 | 72.7 | 75 | 82 | 67 |
| Mean age (years) | 70.1 ± 9.7 | 69.1 ± 8.9 | 62.4 ± 12.7 | 62.6 ± 13.1 | 70.6 ± 8.5 |
| Ischaemic aetiology, n (%) | 59 (67.8) | 21 (63.6) | 24 (66.7) | 10 (58.8) | 21 (58) |
| Diabetes, n (%) | 24 (27.6) | 12 (36.4) | 6 (16.7) | 5 (29.4) | 11 (31) |
| NYHA functional class (%) | |||||
| II | 44.8 | 48.5 | — | 6 | 5.6 |
| III | 52.9 | 51.5 | 94.4 | 94 | 88.8 |
| IV | 2.3 | — | 5.5 | — | 5.6 |
| Atrial fibrillation, n (%) | 57 (58.6) | 20 (60.6) | 12 (33.3) | 2 (11.8) | 17 (47) |
| Device (ICD or PPM), n (%) | 43 (49.4) | 12 (36.4) | 6 (16.7) | 2 (11.8) | |
| 6MWT distance (m) | 306.4 ± 90.5 | 292.6 ± 91.5 | 302 ± 73.6 | 338 ± 83.4 | 294.1 ± 83 |
| LVEF (%) | 34 ± 9 | 37 ± 9 | 29 ± 7 | 27 ± 8 | 34 ± 10 |
| LVEDV (mL) | 187 ± 65.6 | 188.6 ± 75.7 | 208.5 ± 62.0 | 237.4 ± 96.7 | 174.4 ± 51.2 |
| LVESV (mL) | 127.4 ± 56.1 | 122.0 ± 59.8 | 151.7 ± 57.1 | 177.7 ± 91.9 | 119.8 ± 39.6 |
| Mitral regurgitant volume (mL per beat) | 40.4 ± 23.9 | 38.1 ± 24.0 | 34.5 ± 11.5 | 39.9 ± 13.2 | 34.4 ± 13.5 |
| Mitral regurgitant grade (%) | |||||
| 1+ | 28.7 | 32.3 | |||
| 2+ | 39.1 | 25.8 | 19.4 | 11.8 | 28 |
| 3+ | 26.4 | 35.5 | 55.6 | 58.8 | 61 |
| 4+ | 5.7 | 6.5 | 25.0 | 29.4 | 11 |
There were also changes noted in Figure 2. Figure 2 title should read as ‘Changes in mitral regurgitation grade’, and Figure 2 image was previously incorrect. The updated Figure 2 is shown below. Online version has been corrected too to reflect these changes.
Figure 2
(A–F) Forest plots for changes in left ventricular remodelling, mitral regurgitation severity, left atrial volume, and New York Heart Association class at 12 month follow-up. CI, confidence interval.
